help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 1, No. 12 933-941
doi:10.1210/mend-1-12-933
Copyright © 1987 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gertz, B. J.
Right arrow Articles by Baxter, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gertz, B. J.
Right arrow Articles by Baxter, J. D.

Glucocorticoid Control of Rat Growth Hormone Gene Expression: Effect on Cytoplasmic Messenger Ribonucleic Acid Production and Degradation

Barry J. Gertz*, David G. Gardner and John D. Baxter

Metabolic Research Unit and the Departments of Medicine, Biochemistry, and Biophysics, University of California San Francisco, California 94143

Address requests for reprints to: Barry J. Gertz, M.D., Ph.D., Merck Sharp & Dohme Research Laboratories, P.O. Box 2000, WB D-242, Rahway, New Jersey 07065-0914.

Abstract

The effect of the glucocorticoid dexamethasone on the production and degradation of rat GH (rGH) cytoplasmic mRNA was studied in cultured rat pituitary tumor (GC) cells. The incorporation of [3H]uridine into both rGH cytoplasmic mRNA and the pyrimidine nucleotide precursor pool was determined in hormone-treated and control cells. From these measurements glucocorticoid effects on absolute production rates of rGH cytoplasmic mRNA were determined and compared to effects on rGH mRNA accumulation. Rat GH mRNA half-life was then calculated based on a first-order decay model. Rat GH mRNA half-life was also directly assayed by: 1) pulse-chase studies and 2) measuring the kinetics of decay of rGH mRNA in cells after transfer from serum-containing to hormone-deficient media. From these independent analyses rGH mRNA half-life estimates ranged from 28–55 h in different experiments. Within individual experiments there was little variability of rGH mRNA decay rates; glucocorticoids were found not to alter the stability of rGH cytoplasmic mRNA. Glucocorticoid induction of rGH cytoplasmic mRNA accumulation was accounted for solely on the basis of increased mRNA production.

FOOTNOTES

This research was supported by Grant AM-19997 from the National Institutes of Health and a gift from California Biotechnology, Inc.

* Supported by a National Research Service Award from the NIH and a Junior Faculty Research Award from the American Cancer Society. Present address is Merck, Sharp & Dohme Research Laboratories, P.O. Box 2000, Rahway, NJ 07065.

Received for publication September 8, 1987. Accepted for publication October 15, 1987.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Touati, A. M. Prieur, J. C. Ruiz, M. Noel, and P. Czernichow
Beneficial Effects of One-Year Growth Hormone Administration to Children with Juvenile Chronic Arthritis on Chronic Steroid Therapy. I. Effects on Growth Velocity and Body Composition
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 403 - 409.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society